BACKGROUND: Persistent infection with oncogenic human papillomavirus (HPV) is associated with an increased risk of cervical malignancy. Redetection of type-specific HPV after a period of nondetection may be caused by reactivation of a low-level persistent infection. Little is known about factors associated with type-specific HPV redetection. METHODS: For a longitudinal cohort of adolescent women with frequent behavioral and sexually transmitted infection (STI) information (every 3 months), Cox proportional hazard models were used to assess the influence of sexual behaviors and STIs on the redetection of oncogenic or high-risk HPV infections. RESULTS: A total of 210 type-specific high-risk HPV detection episode periods were identified in this longitudinal cohort; 71 (33.8%) were characterized by a period of nondetection followed by redetection. Chlamydia trachomatis (hazard ratio [HR], 3.14; 95% confidence interval [CI], 1.44-6.86) was associated with redetection; redetection was >2 times more likely with each additional self-reported sex partner in the past 3 months (HR, 2.26; 95% CI, 1.35-3.78). CONCLUSIONS: This study demonstrates the role of C. trachomatis and number of recent sexual partners in type-specific HPV redetection. Given that persistent oncogenic HPV infections are associated with cancer-related outcomes, understanding the potential role of such factors in the pathogenesis of HPV-related outcomes is important.
BACKGROUND: Persistent infection with oncogenic human papillomavirus (HPV) is associated with an increased risk of cervical malignancy. Redetection of type-specific HPV after a period of nondetection may be caused by reactivation of a low-level persistent infection. Little is known about factors associated with type-specific HPV redetection. METHODS: For a longitudinal cohort of adolescent women with frequent behavioral and sexually transmitted infection (STI) information (every 3 months), Cox proportional hazard models were used to assess the influence of sexual behaviors and STIs on the redetection of oncogenic or high-risk HPV infections. RESULTS: A total of 210 type-specific high-risk HPV detection episode periods were identified in this longitudinal cohort; 71 (33.8%) were characterized by a period of nondetection followed by redetection. Chlamydia trachomatis (hazard ratio [HR], 3.14; 95% confidence interval [CI], 1.44-6.86) was associated with redetection; redetection was >2 times more likely with each additional self-reported sex partner in the past 3 months (HR, 2.26; 95% CI, 1.35-3.78). CONCLUSIONS: This study demonstrates the role of C. trachomatis and number of recent sexual partners in type-specific HPV redetection. Given that persistent oncogenic HPV infections are associated with cancer-related outcomes, understanding the potential role of such factors in the pathogenesis of HPV-related outcomes is important.
Entities:
Keywords:
HPV redetection; chlamydia; human papillomavirus
Authors: T Anttila; P Saikku; P Koskela; A Bloigu; J Dillner; I Ikäheimo; E Jellum; M Lehtinen; P Lenner; T Hakulinen; A Närvänen; E Pukkala; S Thoresen; L Youngman; J Paavonen Journal: JAMA Date: 2001-01-03 Impact factor: 56.272
Authors: Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi Journal: J Infect Dis Date: 2012-12-12 Impact factor: 5.226
Authors: Kenneth H Fife; Julia W Wu; Kathleen E Squires; D Heather Watts; Janet W Andersen; Darron R Brown Journal: J Acquir Immune Defic Syndr Date: 2009-07-01 Impact factor: 3.731
Authors: Marcia L Shew; J Dennis Fortenberry; Wanzhu Tu; Beth E Juliar; Byron E Batteiger; Brahim Qadadri; Darron R Brown Journal: Arch Pediatr Adolesc Med Date: 2006-02
Authors: Matti Lehtinen; Kevin A Ault; Erika Lyytikainen; Joakim Dillner; Suzanne M Garland; Daron G Ferris; Laura A Koutsky; Heather L Sings; Shuang Lu; Richard M Haupt; Jorma Paavonen Journal: Sex Transm Infect Date: 2011-04-06 Impact factor: 3.519
Authors: Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith Journal: Sex Transm Dis Date: 2015-06 Impact factor: 2.830
Authors: Maira A Castañeda-Avila; Erick Suárez-Pérez; Raúl Bernabe-Dones; Elizabeth R Unger; Gitika Panicker; Ana P Ortiz Journal: P R Health Sci J Date: 2020-03 Impact factor: 0.705
Authors: R Robial; A Longatto-Filho; C M Roteli-Martins; M F Silveira; D Stauffert; G G Ribeiro; I M Linhares; M Tacla; M A Zonta; E C Baracat Journal: Infect Agent Cancer Date: 2017-01-06 Impact factor: 2.965